Medline Inc. Class A Common Stock annual revenue for fiscal TTM was $29.1 billion, an increase of 2.5% from $28.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $29.1B | $28.4B | $25.5B | $23.2B | $21.4B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $7.4B | $7.8B | $7.1B | $6.9B | $6.6B | $6.4B | $6.2B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MDLN metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All MDLN financial statements → Interactive MDLN charts →
About TickerBase · Data methodology & sources